These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32428045)

  • 21. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
    Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
    Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 24. Pluripotent Conversion of Muscle Stem Cells Without Reprogramming Factors or Small Molecules.
    Bose B; Shenoy P S
    Stem Cell Rev Rep; 2016 Feb; 12(1):73-89. PubMed ID: 26358783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
    Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
    Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid.
    Verma R; Holland MK; Temple-Smith P; Verma PJ
    Theriogenology; 2012 Jan; 77(1):220-8, 228.e1-2. PubMed ID: 22079579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
    Nishi M; Sakai Y; Akutsu H; Nagashima Y; Quinn G; Masui S; Kimura H; Perrem K; Umezawa A; Yamamoto N; Lee SW; Ryo A
    Oncogene; 2014 Jan; 33(5):643-52. PubMed ID: 23318426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma.
    Paterson C; Kilmister EJ; Brasch HD; Bockett N; Patel J; Paterson E; Purdie G; Galvin S; Davis PF; Itinteang T; Tan ST
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
    Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
    Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
    Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
    Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
    Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
    J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and Characterization of Human Colon Adenocarcinoma Stem-Like Cells Based on the Endogenous Expression of the Stem Markers.
    Koshkin SA; Anatskaya OV; Vinogradov AE; Uversky VN; Dayhoff GW; Bystriakova MA; Pospelov VA; Tolkunova EN
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early prediction of the differentiation potential during the formation of human iPSC-derived embryoid bodies.
    Guo NN; Liu LP; Zhang YX; Cai YT; Guo Y; Zheng YW; Li YM
    Biochem Biophys Res Commun; 2019 Aug; 516(3):673-679. PubMed ID: 31248595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
    Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
    Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts.
    Sumer H; Liu J; Malaver-Ortega LF; Lim ML; Khodadadi K; Verma PJ
    J Anim Sci; 2011 Sep; 89(9):2708-16. PubMed ID: 21478453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives.
    Bernhardt M; Galach M; Novak D; Utikal J
    Biotechnol J; 2012 Jun; 7(6):810-21. PubMed ID: 22589234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.